Jim Cramer
These are the 4 biggest things we’re watching in the stock market in the week ahead
The stock market heads into Monday on a streak of volatility it just can’t seem to shake. What had been shaping up as a positive holiday-shortened week turned on a dime Wednesday when Federal Reserve Chairman Jerome Powell signaled concern that President Donald Trump ‘s tariffs could increase inflation and slow economic growth. Speaking at […]
Read More
Eli Lilly shares surge on new obesity pill data. What it means for the stock from here
Eli Lilly is tightening its grip on the lucrative weight-loss market as it moves into a new, more convenient phase that promises to broaden the appeal of its breakthrough drugs. The news Club name Lilly said its daily obesity pill was successful in a late-stage trial for Type 2 diabetes — sending shares soaring more […]
Read More
Abbott Labs shares surge on earnings and a big sign of confidence in the business
Shares of Abbott Laboratories jumped Wednesday after the diversified health-care company delivered strong first-quarter results and left its earnings guidance intact — a big sign of confidence in an uncertain time. Revenue in the three months ended March 31 rose 4% to $10.36 billion, narrowly missing the consensus of $10.4 billion, according to estimates compiled […]
Read More
10 beaten-up stocks that are candidates for a rebound — but all are not created equal
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Markets: Stocks are struggling to hold onto gains Tuesday with the market well off its highest levels of the session. Deeply oversold conditions combined with some […]
Read More
Hard-hit Apple bounces back with the market, and an analyst is divided on our drug stocks
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. Wall Street surged Tuesday on increased hopes of tariff deals, following a wickedly volatile session Monday. The Dow Jones Industrial Average climbed around 1,400 points, or 3.7%. The S […]
Read More
We’re exiting our position in a health-care stock to raise some cash
Shortly after the opening bell, we will be exiting our position in GE Healthcare , selling 550 shares at roughly $65. Following Friday’s trade, Jim Cramer’s Charitable Trust will no longer own a position in GEHC. We’re cutting loose our small position in GE Healthcare and raising some cash following two negative developments over the […]
Read More
Don’t overlook the impact of pharma tariffs, says an analyst. Where we stand on Bristol Myers
The drug stock is higher over the past month while the S&P 500 has pulled back sharply. Source
Read More
We’re buying more shares of 2 stocks as the broader market sinks further
We’re making our first trades of the week. We are buying 25 shares of Danaher at roughly $207 each. Following Friday’s trade, Jim Cramer’s Charitable Trust will own 550 shares of DHR, increasing its weighting to 3.5% from 3.35%. We are buying 10 shares of Home Depot at roughly $358. Following the trade, the Trust […]
Read More
Here’s how much Capital One would be worth post-Discover deal, according to one Wall Street firm
How much would Capital One’s stock be worth if it completes its blockbuster merger of Discover Financial Services ? The answer, according to one Wall Street firm, is a whole lot more. The news In a Tuesday note, BTIG analysts said they believe shares of Capital One would be worth $427 apiece if the Discover […]
Read More
Wells Fargo’s strong rebound rally continues. How we’re playing the move higher
Wells Fargo shares rose again Monday amid fresh Wall Street research and a broader market gain. It is tempting to take profits on the Club stock, which has mounted a 10% rally since its lowest close of 2025 on March 10. However, Jim Cramer advised investors to hold on for a little longer. The analysts’ […]
Read More